Printer Friendly
The Free Library
14,669,765 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Molecular Biosystems Announces Commencement Of Clinical Trials For FS069 In Japan.


SAN DIEGO--(BW HealthWire)--Oct. 26, 1998--Molecular Biosystems Inc. (NYSE NYSE

See: New York Stock Exchange
:MB) Monday announced that Chugai Pharmaceuticals Ltd., has begun clinical trials in Japan for FS069, MBI's flagship cardiac ultrasound ultrasound or sonography, in medicine, technique that uses sound waves to study and treat hard-to-reach body areas. In scanning with ultrasound, high-frequency sound waves are transmitted to the area of interest and the returning echoes recorded  imaging agent.

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the companies, development of FS069 is ahead of schedule. FS069, known in parts of the world as OPTISON(R), is approved for sale in both the U.S. and European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the

European Community
. OPTISON has been used commercially worldwide and continues to be the only available agent of its kind. Marketing authorization for FS069 in Japan would give Chugai and MBI MBI Management Buy-In
MBI Moody Bible Institute
MBI Mathematical Biosciences Institute
MBI Modular Building Institute
MBI Mechanical Breakdown Insurance
MBI Molecular Biology Institute
MBI Maslach Burnout Inventory (psychometrics) 
 access to the world's second largest market for ultrasound imaging.

"There is a convergence of many positive developments in Japan which make us extremely enthusiastic about this project," said Howard Dittrich, M.De most advanced ultrasound imaging agent," said an exclusive license agreement for development development and commercialization of ultrasound contrast agents for diagnostic imaging. The company's breaktation about MBI may be obtained via fax by callid Japanese pharmaceutical company, known for its innovative products.

This news release contains forwRNIA

INDUSTRY KEYWORD: BIOTECHNOLOGY COMPe E-Commerce Destination for Entertainment Merchandise

Business Editors & Entertainment Writers

One-Stop-Shop Delivers Expanded Service to E! Online's 2.4 mm

Users and Entertainment Enthusiasts Everywhere

LOS LOS Length of stay, see there  Announced Jeremy Verba, president of E! Online. rchandise spanning every category.

"Our aBy leveraging the power of a 24-hour cable netwse online."

Shop.eonline.com offers thousaased on the relevant entertainment subject matte offering consumers the only online store whereallow us to offer a wide range of products and complete fulfillment ful·fill also ful·fil  
tr.v. ful·filled, ful·fill·ing, ful·fills also ful·fils
1. To bring into actuality; effect: fulfilled their promises.

2.
 services while mitigating mit·i·gate  
v. mit·i·gat·ed, mit·i·gat·ing, mit·i·gates

v.tr.
To moderate (a quality or condition) in force or intensity; alleviate. See Synonyms at relieve.

v.intr.
To become milder.
 financial riskhouse. The store is dedicated to providing optitremendous growth opportunity for e-commerce. Entertainment goods purchased online generated $298 million revenue in 1997 and revenue is projected to be at $591 million for 1998 and over $1 billion by 1999. There was a 37% rise in online shopping from September 1997 to June 1998.

E! Online, the premier entertainment destination on the World Wide Web, delivers original entertainment news, gossip, celebrities, movie and TV information to consumers through an interactive format utilizing the brand awareness and programming of E! Entertainment Television.

The service is available on the World Wide Web at http://www.eonline.com, and operates Moviefinder.com, Your Complete and Personal Movie Connection, located at http://www.moviefinder.com. E! Online Entertainment's Home Page, is a wholly-owned subsidiary of E! Entertainment Television.
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 26, 1998
Words:389
Previous Article:Microware Systems Corporation Showcases Leading Embedded Technology Solutions.
Next Article:Premier UK Videoconferencing Company Opens Office in Reston, Va.
Topics:



Related Articles
Molecular Biosystems reports third-quarter financial results.
OPTISON Recommended for European Approval; New Ultrasound Imaging Agent Will Aid in the Detection of Cardiac Disease.
Molecular Biosystems Completes Myocardial Perfusion Phase 2 Studies; OPTISON Compared Favorably To ``Gold Standard''.
Clinical Uses of MB-840 Highlighted at Contrast Media Research Conference.
MBI Announces Commencement Of Pivotal Clinical Trials For FS069 In Japan; MBI Received $2 Million Payment.
Molecular Biosystems Reports Financial Results for Fiscal 2000 and the Fourth Quarter Ended March 31, 2000.
Molecular Biosystems Inc. Agrees to be Acquired by Alliance Pharmaceutical Corp.
ARGENTINA APPROVES APPLIED BIOSYSTEMS' VIROSEQ KIT.
APPLIED BIOSYSTEMS/BRAZILIAN NMH SIGN PACT FOR GENOTYPING.
FALCO biosystems to Acquire Shida-Iken.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles